DeepMed Research

British Columbia Cancer Agency

Country

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Tailored Adjuvant Therapy in POLE-mutated and p53-wildtype Early Stage Endometrial Cancer

Not Applicable

Completed

Conditions: Endometrial Cancer

First Posted Date: 2021-01-12

Last Posted Date: 2023-08-14

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 42

Registration Number: NCT04705649

Locations: 🇨🇦
BC Cancer - Vancouver Centre, Vancouver, British Columbia, Canada

5500/20 Vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)

Not Applicable

Recruiting

Conditions: Oligometastatic Prostate Cancer

Interventions: Radiation: Permanent seed implant
Radiation: Hypofractionated external beam radiotherapy
Radiation: High dose rate brachytherapy
Radiation: Stereotactic body radiotherapy

First Posted Date: 2020-10-30

Last Posted Date: 2025-03-13

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 168

Registration Number: NCT04610372

Locations: 🇨🇦
British Columbia Cancer Agency Center for the Southern Interior, Kelowna, British Columbia, Canada
🇨🇦
Fraser Valley Cancer Center, Surrey, British Columbia, Canada
🇨🇦
Vancouver Cancer Center, Vancouver, British Columbia, Canada

and more 1 locations

CARA Treatment Pilot Study for Breast Positioning

Not Applicable

Completed

Conditions: Side Effect
Breast Cancer

Interventions: Device: CARA - carbon fibre adjustable re-usable accessory for breast positioning

First Posted Date: 2020-09-10

Last Posted Date: 2020-09-10

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 20

Registration Number: NCT04543851

Locations: 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada

Dynamic Whole Body PET/ MRI

Withdrawn

Conditions: Prostatic Cancer

Interventions: Drug: 68Ga-HTK03149

First Posted Date: 2020-08-03

Last Posted Date: 2025-01-08

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 30

Registration Number: NCT04495959

Locations: 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada

[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer

Active, not recruiting

Conditions: Prostatic Neoplasm
Prostatic Cancer

Interventions: Drug: 68Ga-PSMA-11

First Posted Date: 2020-07-23

Last Posted Date: 2025-05-09

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 1574

Registration Number: NCT04484701

Locations: 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada

Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity

Phase 2

Recruiting

Conditions: Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Skin Cancer
Lung Cancer
Gynecologic Cancer
Head and Neck Cancer
Sarcoma
Unknown Primary Tumors

Interventions: Drug: Atezolizumab

First Posted Date: 2020-02-17

Last Posted Date: 2024-08-21

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 200

Registration Number: NCT04273061

Locations: 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada
🇨🇦
University Health Network / Princess Margaret Cancer Centre, Toronto, Ontario, Canada

Carbon-Fibre Accessory (CARA) for Supine Breast Positioning to Reduce Toxicity in Whole Breast Radiotherapy

Not Applicable

Recruiting

Conditions: Adjuvant Radiotherapy for Breast Cancer

Interventions: Device: Carbon-Fibre Adjustable Reuseable Accessory (CARA)

First Posted Date: 2020-02-06

Last Posted Date: 2023-01-25

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 220

Registration Number: NCT04257396

Locations: 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada

18F-AmBF3-TATE PET/CT for Imaging NET Patients

Completed

Conditions: Neuroendocrine Tumors

Interventions: Diagnostic Test: 18F-AmBF3-TATE PET/CT
Diagnostic Test: Routine blood draw

First Posted Date: 2019-12-23

Last Posted Date: 2021-01-20

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 10

Registration Number: NCT04207762

Locations: 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada

Real-world Clinical Effectiveness of Whole Genome and Transcriptome Analysis to Guide Advanced Cancer Care

Conditions: Cancers That Cannot be Treated With Curative Intent
Advanced Cancer
Metastatic Cancer

Interventions: Genetic: Usual care
Genetic: Initiation of POG-related WGTA

First Posted Date: 2019-10-28

Last Posted Date: 2021-01-27

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 1200

Registration Number: NCT04141397

Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging

Conditions: Prostate Cancer
Prostatic Neoplasms
Neuroblastoma
Neuroendocrine Tumors
Carcinoid Tumor
Paraganglioma

Interventions: Diagnostic Test: 18F-FDG PET/CT
Diagnostic Test: 68Ga-DOTATOC PET/CT
Diagnostic Test: 18F-DCFPyL PET/CT

First Posted Date: 2019-07-12

Last Posted Date: 2021-01-26

Lead Sponsor: British Columbia Cancer Agency

Target Recruit Count: 60

Registration Number: NCT04017104

Locations: 🇨🇦
BC Cancer, Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy